Ilex Capital Partners (Uk) LLP Charles River Laboratories International, Inc. Transaction History
Ilex Capital Partners (Uk) LLP
- $2.45 Trillion
- Q1 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 10,585 shares of CRL stock, worth $1.45 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,585Holding current value
$1.45 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
650Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$835 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$696 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$586 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$327 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$267 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.95B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...